Experienced in genomics research with a focus on large-scale genome sequencing projects and rare disorders. Previously at the Wellcome Trust Sanger Institute and the University of Cambridge.
Experienced in single-cell genomics research, studying childhood cancer. Previously at the Wellcome Trust Sanger Institute, the University of Cambridge and JPMorgan.
Computer scientist previously working on deep learning and genetics at the Wellcome Trust Sanger Institute and the University of Cambridge.
- El LittenFront End Developer
- Daniel MurrellSoftware Engineer
- Adam FaulconbridgeBioinformatician
- Hamzah HusseiniFull Stack Developer
- Hiring nowFull Stack Developer
- Joe BallHead of marketing
- Clare ClarkeCommunity Manager
- Georgia HingstonContent Manager
- Hiring nowSenior Product Manager
Business Development Team
- Ross RounsevellResearch Partnerships
- Liam EvesCommercial Strategist
- Hannah ThompsonBusiness Development Executive
- Hiring nowProject Manager
- Dr Paul WicksScientific Advisor
- Paul ForsterInvestor and Board Member
- Rosie HigginsProduct Advisor
Our Cambridge Office
Salisbury Villas, Station Rd, Cambridge CB1 2LA
Here you can find the answers to the most common questions about Sano.
If your query isn’t featured here, or you need more information, please don’t hesitate to get in touch by email or via the chat service.
We make money by providing tools for researchers to analyse anonymous and aggregated data that is provided by Sano users when they choose to participate in research.
We also help researchers to recruit for their research studies and clinical trials based on data that Sano users provide, if they have opted to share it for this purpose. We believe medical research should be transparent, interactive, and beneficial to everyone involved. This is why we always ask for permission and, whenever possible, provide a complete summary of the research findings and offer financial compensation to participants.
In addition to this, we believe that users should share in the value generated from their data, which is why we’re working with researchers to offer paid studies. We ran our first paid study with Owlstone Medical in October 2019.
Your data will never be sold without your permission. We built Sano Genetics because we believe we should not have to choose between data privacy and access to cutting edge research. We don't believe in business models shrouded in secrecy, where users find out their data has been sold on through a national news scandal.
We use industry standard encryption mechanisms both in transit and at rest when dealing with your data.This means that your data is safe and secure, whether or not you choose to share it.
Any information sent between your computer and our servers is encrypted using SSL - you can always check that the padlock icon in your internet browser is present to ensure you are interacting with our site, and not a site trying to impersonate us to steal your data.
We are values driven. We believe any company, but particularly companies specialising in DNA sequencing, should have ethical practices, transparent communication and a business model which is socially responsible.
We also use more advanced DNA sequencing technology (whole exome sequencing and whole genome sequencing) than most other companies, providing much more data and enhancing the quality of insights. We are also committed to keeping you updated on new advances in genomics; by joining Sano you are signing up to a lifetime of new insight.